Ann: Successful BARD1 Kit Evaluation, page-27

As a former Sienna person, we got the better end of the deal initially but I think BD-1 will gain much more momentum. You are correct in that the Sienna management were totally useless, but things are now different and the Nobel prize winning testing background we have has to come to good use in the near future. I got in on the float and saw the seed capital investors bail on day one. What did that tell us all ? That SDX management were crap, but as they say good things come to those that wait. But for someone with a cancer issue, good things can be detected early. The market is huge don't forget.